Capital Markets

Gaby SmeenkJaap Barneveld + 10 other experts

Flexible, innovative capacity to spearhead niche transactions

We partner with our clients on their complex matters, marrying our expertise with transaction management skills, out-of-the-box thinking, and an adept gambit of innovative solutions. Our high deal flow ensures that our Capital Markets team is always aware of both regulators' perspectives and of current market practice.

Our two dedicated teams:

  • Equity Capital Markets - the largest pure-play equity capital markets team in the Netherlands, and
  • Debt Capital Markets - located in both London and Amsterdam.

maintain a worldwide network of leading law firms, and regularly work with them in fixed teams, and offer our clients first-class, cross-border services.

De Brauw7 Mrt 0479

Equity Capital Markets

Involved in almost all major Dutch IPOs, we advise corporates and financial institutions with unrivalled advice in

• IPOs;
• listed and unlisted share issues
• share buy-back programmes
• convertible bonds and derivatives

De Brauw has the preeminent equity capital markets team in the Netherlands on the issuer side. Their depth of skill, experience and knowledge is unparalleled. (...) Where they really shine is in the most complex transactions, such as multiple listings, cross border transactions and dual track spin-offs. I would put my company's most crucial cases in their hands without hesitation.

Legal 500, 2026

Insights

24 June 2026

Multiple-vote shares directive: Dutch implementation one step closer

On 9 June 2026, a bill implementing the EU directive on multiple-vote share structures (MVS Directive) was submitted to the Dutch lower house. The directive allows companies seeking admission to trading on a multilateral trading facility (MTF), to introduce share structures where certain classes of shares provide more votes per share than other classes (high-vote/low-vote share structures). Importantly, the bill leaves untouched existing Dutch mechanisms for differentiating voting rights – including high-vote/low-vote structures and loyalty voting schemes. The implementing bill that has now been submitted is mainly of interest to small and medium-sized companies (SMEs) and does not affect companies listed on a regulated market.
15 April 2026

De Brauw and hollandbio to host event on scaling beyond Series C

Hollandbio and De Brauw Blackstone Westbroek are hosting an exclusive session on scaling beyond Series C on 21 May. As biotech companies enter later stages of growth, the rules of the game change. Financing rounds become more complex, investor expectations intensify and governance frameworks require further development. How do companies successfully navigate through this next phase of growth?
13 February 2026

Side-by-side: will acceptance of US minimum taxation standards impact EU competitiveness?

On 5 January 2026, the OECD published the Side-by-Side (SbS) Package. This package complements the OECD Inclusive Framework's model rules aimed at securing global 15% minimum taxation for large multinationals (referred to as "Pillar 2"). These minimum taxation rules have been implemented within the EU with effect from 1 January 2024.